These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 17918704

  • 1. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
    Zhou WQ, Sun YH, Yin HL, Zhang ZY, Ge JP, Cheng W, Ma HQ, Wei W, Zhou SG, Ma HH, Gao JP.
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
    [Abstract] [Full Text] [Related]

  • 2. [Expression of VEGF in prostate cancer and its correlation with ET-1].
    Zhou WQ, Yin HL, Zhang ZY, Yi XM, Ge JP, Zhou SG, Cheng W, Wei W, Ma HQ, Ma HH, Gao JP.
    Zhonghua Nan Ke Xue; 2008 Nov; 14(11):987-92. PubMed ID: 19102498
    [Abstract] [Full Text] [Related]

  • 3. [Analysis of the differences in the expression of HSP27 and c-kit between benign prostatic hyperplasia and prostatic cancer tissues].
    Zhen B, Shen Y, Zhang YM, Zhu CH, Liu ZL.
    Zhonghua Nan Ke Xue; 2006 May; 12(5):416-20. PubMed ID: 16755871
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of the leptin and leptin receptor expressions in prostate tissues.
    Hoon Kim J, Lee SY, Myung SC, Kim YS, Kim TH, Kim MK.
    Asian J Androl; 2008 Nov; 10(6):923-8. PubMed ID: 18958356
    [Abstract] [Full Text] [Related]

  • 5. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
    Wang FL, Wang H, Qin WJ, Wu GJ, Zhang G, Li KN.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
    [Abstract] [Full Text] [Related]

  • 6. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R, Liu ZY, Sun YH, Xu CL, Gao X, Jiao L.
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z, Wenlv S.
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Expressions of telomerase reverse transcriptase and vascular endothelial growth factor and their correlation in prostate cancer].
    Li X, Wang N, Zhang Y, Zhang SX, Lin Q, Tang J.
    Zhonghua Nan Ke Xue; 2005 Oct; 11(10):724-6, 730. PubMed ID: 16281501
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [P53 expression and its clinical significance in prostatic carcinoma].
    Jiang T, Jiang H, Song XS, Li XC, Li QL.
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):448-51, 454. PubMed ID: 15999492
    [Abstract] [Full Text] [Related]

  • 15. [Expression and significance of PCNA and p27 in benign prostate hypertrophy and prostate carcinoma].
    Lai JS, Xia Q, Zhang XB, Zhao GP, Xu SL, Zheng DS.
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):476-8. PubMed ID: 15555337
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
    Zhong WD, Han ZD, He HC, Bi XC, Dai QS, Zhu G, Ye YK, Liang YX, Qin WJ, Zhang Z, Zeng GH, Chen ZN.
    Oncology; 2008 Aug; 75(3-4):230-6. PubMed ID: 18852494
    [Abstract] [Full Text] [Related]

  • 18. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
    Thomas LN, Douglas RC, Vessey JP, Gupta R, Fontaine D, Norman RW, Thompson IM, Troyer DA, Rittmaster RS, Lazier CB.
    J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
    [Abstract] [Full Text] [Related]

  • 19. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
    Trojan L, Michel MS, Rensch F, Jackson DG, Alken P, Grobholz R.
    J Urol; 2004 Jul; 172(1):103-7. PubMed ID: 15201747
    [Abstract] [Full Text] [Related]

  • 20. [Expression of nucleosomal binding protein 1 in normal prostate benign prostate hyperplasia, and prostate cancer and significance thereof].
    Song G, Zhou LQ, Weng M, He Q, He ZS, Hao JR, Pan BN, Na YQ.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 25; 86(28):1962-5. PubMed ID: 17064590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.